Endocrinology
| Testosterone
Endocrinology
Testosterone
Adverse Cardiovascular Events and All-Cause Mortality in Men During Testosterone Treatment: Individual Patient and Aggregate Data Meta-Analyses
book_2
Source:
ENDO 2022 - Oral Session
calendar_today
Published on Medfyle:
June 2022
import_contacts
5
min
In this medfyle
This meta-analysis found no evidence that testosterone increases the risk of mortality or cardiovascular and/or cerebrovascular events in men with low testosterone levels.
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
About this Medfyle
Read more
arrow_downward
Hide
arrow_upward
This is a highlights summary of an oral session given at the ENDO 2022 Annual Conference and presented by:
Channa Jayasena, PhD
Imperial College London Faculty of Medicine, Hammersmith Hospital
London, UK
The content is produced by Infomedica, the official reporting partner of ENDO 2022.
The presenting authors of the original session had no part in the creation of this conference highlights summary.
